Drug Type Antibody |
Synonyms- |
Target |
Mechanism FGF23 antagonists(Fibroblast growth factor 23 antagonists), FGFR4 antagonists(Fibroblast growth factor receptor 4 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Kidney Diseases | Discovery | CH | 27 Jul 2023 | |
Hypertrophy, Left Ventricular | Discovery | CH | 27 Jul 2023 |